Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Juan F Bulnes"'
Autor:
German E. Ramos, Christian Caglevic, Juan F. Bulnes, Sergio E. Panay, Mario I. Zapata, Andrés J. Daniele, Manuel E. Rodríguez
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 9 (2022)
Endothelial Growth Factor Receptor (EGFR) mutations are frequently found among NSCLC patients. Second-generation Tyrosine Kinase Inhibitor (TKI) Afatinib is frequently used in this population of patients achieving better results than cytotoxic chemot
Externí odkaz:
https://doaj.org/article/82654d635cd445d090bd7219a0daaa9d
Autor:
Juan F Bulnes, Alejandro Martínez, Pablo Sepúlveda, Alberto Fuensalida, Santiago Besa, Luis Garrido, Gonzalo Martínez
Publikováno v:
Perfusion. :026765912311784
Introduction High-risk procedures in interventional cardiology include a wide spectrum of clinical and anatomical scenarios related to a higher periprocedural morbidity and mortality. The prophylactic use of short-term mechanical circulatory support
Autor:
Francisco Pacheco, Alberto Fuensalida, Pablo Sepúlveda, René Hameau, Felipe Castañía, Gonzalo Martínez, Juan F Bulnes, Alejandro Martínez, Marcela Adasme, Jorge Quitral, Patricio Mellado
Publikováno v:
Revista chilena de cardiología v.39 n.2 2020
SciELO Chile
CONICYT Chile
instacron:CONICYT
SciELO Chile
CONICYT Chile
instacron:CONICYT
Resumen: Introducción: El cierre percutáneo del foramen oval permeable (FOP) se ha posicionado como el tratamiento de elección para la prevención secundaria de pacientes con infartos encefálicos (IE) criptogénicos asociados a FOP. Objetivo: Rev
Publikováno v:
European Heart Journal: Case Reports
Autor:
Ulises Novoa, Luigi Gabrielli, Claudio Cantin, Juan F Bulnes, Samuel Córdova, María Paz Ocaranza, Paul MacNab, Jorge E. Jalil, Iván Godoy
Publikováno v:
Current Vascular Pharmacology. 18:87-91
Background: Angiotensin II is a potent activator of the Rho-kinase (ROCK) pathway, through which it exerts some of its adverse vasoconstrictor effects. Clinical evidence on the effects of blocking the angiotensin II receptor 1 on ROCK activity in hyp
Publikováno v:
JACC Case Reports
Quadricuspid aortic valve is rare and requires surgery when symptomatic severe regurgitation/stenosis is present. Associated anomalous coronary ostia location demands accurate diagnosis to avoid intraoperative complications, and several imaging techn
Autor:
Martín Lasso, Juan F. Bulnes, Rodrigo Saavedra, Mauricio García, Miguel A. Díaz, Vicente Sandoval, Raquel Rocha, Felipe Guzman, Pablo Varas
Publikováno v:
Chest. 155(5)
Case Presentation A previously healthy 45-year-old man was admitted to our ED with a 3-week history of progressive dyspnea on exertion. He also presented with orthopnea, paroxysmal nocturnal dyspnea, and mild ankle swelling, but he showed no fever, w
Autor:
Benjamín Sanfuentes, Juan F Bulnes
Publikováno v:
Medwave, Vol 18, Iss 07, Pp e7331-e7331 (2018)
There are several effective therapeutic alternatives for stable coronary artery, in terms of prevention of cardiovascular morbidity and mortality. However, the best way to achieve symptomatic control is a matter of debate, particularly in those who d
Autor:
Jorge E. Jalil, Juan F Bulnes
Publikováno v:
Heart Failure Clinics. 11:529-541
The newly available clinical guidelines in heart failure (HF) from Europe (2012), the United States (2010 and 2013), and Canada (2015) were compared, focusing on the systems for grading the evidence and classifying the recommendations, HF definitions
Autor:
Gonzalo Rivera, Patricia García, Maria Cristina Ajenjo, Claudia Castillo, Jaime Labarca, Juan F Bulnes
Publikováno v:
Journal of infection in developing countries. 10(1)
Introduction: Acinetobacter baumannii causes severe infections that primarily affect intensive care unit (ICU) patients. It has a high prevalence of multidrug resistance, including carbapenems, and a high potential for intra-hospital and inter-hospit